 |
| |
| For Immediate Release |
| |
Prodesse
announces release of reagents for detection of newly discovered
human metapneumovirus
WAUKESHA, WI (March 8, 2006) – Prodesse, Inc. announced today
that it has released reagents for sale to CLIA laboratories who can
incorporate them into their development and validation of Real Time
PCR assays which can be used to detect the newly discovered human
metapneumovirus (hMPV). Patent rights to hMPV are held by ViroNovative
BV, Netherlands, which has licensed Prodesse to produce reagents
to detect the human metapneumovirus (hMPV) analyte. Prodesse currently
has the only commercially available licensed PCR reagents for labs
to use in assays they develop to detect hMPV. |
|
About Prodesse
Prodesse is a biotechnology company focused on developing analyte
specific reagents that can be used by CLIA certified laboratories
to develop assays for detecting infectious disease pathogens.
The Company's reagents incorporate proprietary technology that
allows for the detection of multiple pathogens. Prodesse currently
offers nine different multiplex products covering 33 different
organisms. The company’s products can be used on a variety
of detection platforms. The Company sells its reagents to laboratories
throughout the US and the world, and also operates a CLIA certified
laboratory for testing services in the Midwest area. For more
information about Prodesse and its products, call 888-589-6974
or go to www.prodesse.com.
|
| |
| |
Press Contact:
Andy Shrago, Chief Marketing Officer
Prodesse, Inc.
Phone: (262) 446-0700
ashrago@prodesse.com |
| |
|
| |
|
